USLU, S. 2023. PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?. Acta Endocrinologica , vol.19, no.3 , 376-379.

USLU, S., (2023). PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?. Acta Endocrinologica , vol.19, no.3, 376-379.

USLU, SADETTİN. "PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?," Acta Endocrinologica , vol.19, no.3, 376-379, 2023

USLU, SADETTİN. "PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?." Acta Endocrinologica , vol.19, no.3, pp.376-379, 2023

USLU, S. (2023) . "PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?." Acta Endocrinologica , vol.19, no.3, pp.376-379.

@article{article, author={SADETTİN USLU}, title={PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?}, journal={Acta Endocrinologica}, year=2023, pages={376-379} }